H
Hwang, Sung Hee
H指数:0
被引数:0
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Dual acting inhibitor of soluble epoxide hydrolase and Cyclooxygenase-2, attenuates glomerular injury in renal hypoplasia mice
可溶性环氧合酶水解酶和环氧化酶-2的双效抑制剂,可减轻肾发育不全小鼠的肾小球损伤
Inhibition of soluble epoxide hydrolase in endotoxin induced pig lung injury
内毒素诱导的猪肺损伤中可溶性环氧水解酶的抑制
Coamorphous Solid Dispersion of a Soluble Epoxide Hydrolase Inhibitor t-TUCB with Amino Acid L-Arginine
可溶性环氧合酶抑制剂t-TUCB与氨基酸L-Arginine形成的共形态固体分散体
Inhibition of soluble epoxide hydrolase confers neuroprotection and restores microglial homeostasis in a tauopathy mouse model
抑制可溶性环氧合酶水解酶可提供神经保护作用,并在tau病小鼠模型中恢复小胶质细胞的稳态。
A Soluble Epoxide Hydrolase Inhibitor Improves Cerebrovascular Dysfunction, Neuroinflammation, Amyloid Burden, and Cognitive Impairments in the hAPP/PS1 TgF344-AD Rat Model of Alzheimer's Disease
一种可溶性环氧合酶水解酶抑制剂可改善hAPP/PS1 TgF344-AD大鼠模型中阿尔茨海默病的相关脑血管功能障碍、神经炎症、淀粉样蛋白负荷和认知障碍。
Inhibition of Soluble Epoxide Hydrolase Reduces Inflammation and Myocardial Injury in Arrhythmogenic Cardiomyopathy
可溶性环氧合酶水解酶的抑制可减轻心律失常性心肌病中的炎症和心肌损伤
Quantification of soluble epoxide hydrolase inhibitors in experimental and clinical samples using the nanobody-based ELISA
使用基于纳米抗体的ELISA定量实验和临床样品中的可溶性环氧化物水解酶抑制剂
Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer
PTUPB对AKR1C3和雄激素受体轴的新型抑制作用协同恩杂鲁胺治疗晚期前列腺癌
ONCOGENE
IF7.3
Polyunsaturated Fatty Acids Mend Macrophage Transcriptome, Glycome, and Phenotype in the Patients with Neurodegenerative Diseases, Including Alzheimer's Disease
多不饱和脂肪酸可改善包括阿尔茨海默病在内的神经退行性疾病患者的巨噬细胞转录组,糖组和表型

